Kraig Biocraft Laboratories, Inc. (KBLB)
OTCMKTS · Delayed Price · Currency is USD
0.14054
+0.01154 (8.95%)
At close: Apr 15, 2026

KBLB Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1.790.672.553.862.36
Short-Term Investments
---0.1-
Cash & Short-Term Investments
1.790.672.553.962.36
Cash Growth
165.90%-73.62%-35.58%68.20%188.29%
Inventory
0.030.010.010.01-
Prepaid Expenses
0.050.060.010.020.01
Total Current Assets
1.870.742.573.982.37
Property, Plant & Equipment
0.20.130.160.150.22
Long-Term Investments
0.490.630.490.440.44
Other Long-Term Assets
0.010.01000
Total Assets
2.571.513.234.573.02
Accounts Payable
0.510.50.930.90.59
Accrued Expenses
8.47.456.265.424.96
Short-Term Debt
1.491.621.651.712.16
Current Portion of Long-Term Debt
----0.06
Current Portion of Leases
0.050.050.040.040.04
Other Current Liabilities
----0.35
Total Current Liabilities
10.459.618.898.078.16
Long-Term Debt
----0.1
Long-Term Leases
0.120.040.050.020.06
Total Liabilities
10.569.658.948.098.32
Common Stock
31.0227.3927.3927.0822.39
Additional Paid-In Capital
12.4312.2911.3510.839.89
Retained Earnings
-56.71-53.09-49.69-46.66-42.81
Comprehensive Income & Other
0.020.020.02-0.02
Total Common Equity
-13.24-13.39-10.92-8.74-10.51
Shareholders' Equity
-8-8.15-5.71-3.52-5.3
Total Liabilities & Equity
2.571.513.234.573.02
Total Debt
1.661.71.751.772.42
Net Cash (Debt)
0.13-1.030.82.19-0.07
Net Cash Growth
---63.30%--
Net Cash Per Share
0.00-0.000.000.00-0.00
Filing Date Shares Outstanding
1,1001,0431,0381,033950.91
Total Common Shares Outstanding
1,0841,0381,0381,031927.38
Working Capital
-8.58-8.87-6.31-4.09-5.8
Book Value Per Share
-0.01-0.01-0.01-0.01-0.01
Tangible Book Value
-13.24-13.39-10.92-8.74-10.51
Tangible Book Value Per Share
-0.01-0.01-0.01-0.01-0.01
Machinery
0.190.180.180.170.17
Leasehold Improvements
0.080.080.080.080.08
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.